Accounting or accounting process of a person or of an organization has become very complex as it is being used more. But everything in this world is going on maintaining some rules, regulations or principles or guidelines. Accounting is not beyond this. Accounting has some specific principles Followed all over the world for preparing a financial statement & providing disclosures related to the financial statement. Ratio analysis is the important part of Financial Statement to provide relative measurement of different element or event related to investment and for various types of ratio analysis and some other activities. It helps investors to summarize the overall information about a particular company. Here, this paper is about Ratio Analysis based on the annual report of 2007, 2008, 2009, 2010 and 2011 of BEXIMCO PHARMACEUTICALS LTD.
The presentation is about the Analysis of the collected annual report of BEXIMCO PHARMACEUTICALS LTD. The contents of the term paper is the best possible information available thus preserving the confidentiality of the company’s policies and procedures. Only the factors affecting the interested parties and the problems faced by them are presented here.
BEXIMCO PHARMACEUTICALS
BEXIMCO PHARMACEUTICALS LTD is a leading edge pharmaceutical company based in Bangladesh and is acclaimed for its outstanding product quality, worldclass manufacturing facilities, product development capabilities and outstanding professional services. Beximco Pharma is the pioneer in pharmaceutical industry. Overseas Offices & Associates: Australia, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines, Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen Details Year of Establishment Commercial Production Status Years 1976 1980 Public Limited Company
ANALYSIS OF THE RATIOS
LIQUIDITY RATIOS
Type of Ratio Current Ratio
2011 2.699406